RxDoctor Payments Data

Scott Koepsell

Anatomic Pathology & Clinical Pathology · Omaha, NENPI 1316144611

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $72,728 of the $116,623 with a category attached, or 62.4%. AstraZeneca accounts for 78.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $32,874 and has fallen 83.7% since, to $5,355 in 2025. Among anatomic pathology & clinical pathology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,623in general payments, 2019–2025

Across 143 payments — averaging $815.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$92K
  • Instrumentation Laboratory Company$25K
  • Beckman Coulter, Inc.$34
  • Axogen$31
  • Incyte Corporation$16
  • Werfen USA LLC$10
$1,777,920in research payments, 2019–2025

Across 34 payments — averaging $52,292 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Terumo BCT, Inc.$1.1M
  • Instrumentation Laboratory Company$703K
  • Biokit Research And Development, S.l.u.$8K

What the payments were for

  • Consulting fees$18,50016%
  • Speaking & faculty fees$72,72862%
  • Travel & lodging$23,06220%
  • Food & beverage$2,3332%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca119$91,503
Instrumentation Laboratory Company19$25,028
Beckman Coulter, Inc.2$34
Axogen1$31
Incyte Corporation1$16
Werfen USA LLC1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,623 in reported general payments places this provider in the 95th percentile of 83 anatomic pathology & clinical pathology providers in Nebraska.

See all anatomic pathology & clinical pathology providers in Nebraska

Medicare billing

Part B allowed, 2024
$70,368
Medicare patients
1,459
Services billed
3,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →